• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Cohero Health oversubscribes Series A for connected respiratory tech

March 16, 2017 By Sarah Faulkner

Cohero Health oversubscribes Series A for connected respiratory techCohero Health said today that it oversubscribed its $9 million Series A round with investments from Samsung Next and Omron Healthcare

The latest contributions will be used to support commercialization of hardware and software for its BreatheSmart connected respiratory disease management platform, the N.Y.-based company said.

“BreatheSmart from Cohero Health provides both connected hardware and software as an integrated platform, with a high attention to usability – this is no easy feat. We are especially impressed with how the team developed their range of mobile spirometers, which required significant work around manufacturing, clinical efficacy and regulatory approval,” Amit Garg, principal at Samsung Next, said in prepared remarks. “We are looking into how healthtech startups can use software and services to make a disruptive impact into chronic disease management. Cohero Health has created a great solution for respiratory care, tackling the opportunity to help 50 million Americans and 300 million worldwide who suffer from asthma and COPD.”

“Our goal is to ensure that every respiratory patient is empowered to take control of their health, and to prevent avoidable hospital and emergency room visits as a result of uncontrolled respiratory issues,” Omron Healthcare exec Kenji Eda added. “We believe that there is a huge opportunity for Cohero Health and Omron Healthcare to collaborate on the introduction of new products and services linked to BreatheSmart, giving patients and healthcare providers deeper insight into patient health, and reducing the risk of future negative events.”

“Samsung Next and Omron Healthcare support our mission to improve respiratory care through smart mobile devices. These leading technology companies have the scale and expertise that are invaluable to early stage companies like ours,” Cohero co-founder & CEO Melissa Manice said. “We see significant benefit in partnering with well established organizations such as Samsung and Omron Healthcare, while we remain focused on achieving platform scalability through interoperability and effective respiratory stakeholder collaboration.”

In February, the company raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. Cohero sold nearly all of its total offering amount of $13.6 million before closing the round. Over 50 investors have contributed to the offering, which had its 1st sale in October last year.

Filed Under: Featured, Funding Roundup, Patient Monitoring, Respiratory, Wall Street Beat Tagged With: Cohero Health

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS